Danielle Hohmeier

Director of Marketing at Juristat

The Most Difficult Examiners at the USPTO (2023)

The Most Difficult Examiners at the USPTO (2023)

When it comes to patent prosecution, knowing your examiner’s allowance rate can give you a great insight into the road that lies ahead. 

Read More
Six Key Trends From Juristat’s 2022 Top Patent Firms in the US

Six Key Trends From Juristat’s 2022 Top Patent Firms

Time to dive deeper into key trends behind this year’s rankings.

Read More
The USPTO announced it extended the DOCX deadline again, this time to April 3, 2023.

USPTO Delays Switch to DOCX Filings…Again

The USPTO first announced in August 2020 that it would be imposing a new fee for patent applications not filed in DOCX format beginning on January 1, 2022. After multiple extensions,  the USPTO announced that the deadline is now June 30, 2023.  

Read More

USPTO Going All-In on DOCX Filings


The USPTO recently published a final rule announcing that it would encourage the transition to filing in DOCX format by imposing new fees on certain documents submitted in a non-DOCX format. The new rule takes effect on April 3, 2023.*

Read More
2022 was an exciting year for Juristat. We’re excited for 2023, but first, let’s look back at the topics that most interested patent professionals in the past year.

Most-Read Posts of 2022

2022 was an exciting year for Juristat. We launched new products like PTAB Expert Search, expanded our industry-leading analytics with 102 Forward Cite Reports, and improved our cutting-edge workflow automation tools to include Juristat OAR with Detailed Figure Annotations.

Read More

How COVID-19 Affected International Patent Filings

A new study from the Centre for Economic Policy Research tracks the COVID-19 pandemic’s effects on international patent filings and comes up with some surprising results. 

Read More
Patents 4 Patients Program Extended

USPTO Extends Patents 4 Patients Program Through January 2023

In 2016, the USPTO launched the Patents 4 Patients program to support the $1 billion National Cancer Moonshot initiative. In September of this year, the USPTO announced that the pilot program would be extended through January 31, 2023.

Read More
patent news report 2022

2022 Mid-Year Patent News Update

We are nearing the halfway point of 2022, with a new director at the USPTO, another opportunity to clarify the §101 patent eligibility framework, and a pair of bills poised to innovate the semiconductor industry. Here’s what you need to know about the year in patents so far.

Read More

The Most and Least Common Patent Petitions at the USPTO

There are two types of patent petitions: petitions that are so routine you can do them in your sleep and those so rare you don’t even know where to start. Here are the most and least common petitions filed at the USPTO.

Read More
USPTO Patent Pro Bono Program

USPTO Pro Bono Program Supports Under-Resourced Inventors

The USPTO’s Patent Pro Bono Program, established in 2011 as a component of the Leahy-Smith America Invents Act, connects small business owners and inventors with pro bono representation to ease the burden of expensive and time-consuming patent prosecution.

Read More

Are you ready to transform your patent practice?

Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.